- Home
- VTSI vs IKNA Comparison
VTSI vs IKNA Comparison
Compare VTSI & IKNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTSI
- IKNA
- Stock Information
- Founded
- VTSI 1993
- IKNA 2016
- Country
- VTSI United States
- IKNA United States
- Employees
- VTSI N/A
- IKNA N/A
- Industry
- VTSI Miscellaneous manufacturing industries
- IKNA Biotechnology: Pharmaceutical Preparations
- Sector
- VTSI Consumer Discretionary
- IKNA Health Care
- Exchange
- VTSI Nasdaq
- IKNA Nasdaq
- Market Cap
- VTSI 70.9M
- IKNA 83.0M
- IPO Year
- VTSI N/A
- IKNA 2021
- Fundamental
- Price
- VTSI $6.48
- IKNA $1.68
- Analyst Decision
- VTSI Strong Buy
- IKNA Buy
- Analyst Count
- VTSI 2
- IKNA 2
- Target Price
- VTSI $14.50
- IKNA $3.00
- AVG Volume (30 Days)
- VTSI 62.2K
- IKNA 41.6K
- Earning Date
- VTSI 11-12-2024
- IKNA 11-07-2024
- Dividend Yield
- VTSI N/A
- IKNA N/A
- EPS Growth
- VTSI 52.41
- IKNA N/A
- EPS
- VTSI 0.63
- IKNA N/A
- Revenue
- VTSI $31,848,960.00
- IKNA $1,844,000.00
- Revenue This Year
- VTSI N/A
- IKNA N/A
- Revenue Next Year
- VTSI $28.48
- IKNA N/A
- P/E Ratio
- VTSI $10.18
- IKNA N/A
- Revenue Growth
- VTSI N/A
- IKNA N/A
- 52 Week Low
- VTSI $4.57
- IKNA $1.02
- 52 Week High
- VTSI $17.68
- IKNA $4.63
- Technical
- Relative Strength Index (RSI)
- VTSI 56.57
- IKNA 51.57
- Support Level
- VTSI $6.28
- IKNA $1.68
- Resistance Level
- VTSI $6.70
- IKNA $1.78
- Average True Range (ATR)
- VTSI 0.25
- IKNA 0.04
- MACD
- VTSI 0.04
- IKNA 0.00
- Stochastic Oscillator
- VTSI 77.03
- IKNA 36.36
About VTSI VirTra Inc.
VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company includes installation, training, limited warranties, service agreements and related support. The company sells and supports use of force training and marksmanship firearms training systems and accessories for law enforcement, military or civilian use. The product line of the company includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire and other accessories.
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.